Clinical Trial Update: Topical Agent for Treatment of Red Skin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a topical agent for rosacea and related red cheek skin has completed enrollment. The study is sponsored by Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Topical agent for treatment of red skin

Snippet

Sponsor: Mayo Clinic | Conditions: Rosacea, Bilaterally Symmetric Red Skin on Cheeks | Phase 1 | Status: COMPLETED